Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Pilot Study Of Rituximab Plus CHOP In Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia

NCT00060346 is registered in ClinicalTrials.gov with Eastern Cooperative Oncology Group as lead sponsor.

NCT NCT00060346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00060346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Pilot Study Of Rituximab Plus CHOP In Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
Lead sponsor
Eastern Cooperative Oncology Group
Phase
Phase 2
Overall status
Terminated
Start date
October 5, 2004
Completion date
August 31, 2012
Enrollment
16 (actual)
Sites
153

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma